Form 8-K - Current report:
SEC Accession No. 0001213900-25-007698
Filing Date
2025-01-29
Accepted
2025-01-29 08:53:14
Documents
17
Period of Report
2025-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0228987-8k_pluri.htm   iXBRL 8-K 43353
2 FORM OF PRE-FUNDED WARRANT ea022898701ex4-1_pluri.htm EX-4.1 79809
3 FORM OF WARRANT ea022898701ex4-2_pluri.htm EX-4.2 79664
4 SECURITIES PURCHASE AGREEMENT ea022898701ex10-1_pluri.htm EX-10.1 275792
5 BINDING TERM SHEET ea022898701ex10-2_pluri.htm EX-10.2 52539
  Complete submission text file 0001213900-25-007698.txt   824913

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE plur-20250123.xsd EX-101.SCH 3030
7 XBRL LABEL FILE plur-20250123_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE plur-20250123_pre.xml EX-101.PRE 22369
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0228987-8k_pluri_htm.xml XML 3680
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 25566920
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)